Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
1.430
-0.060 (-4.03%)
At close: Mar 28, 2025, 4:00 PM
1.427
-0.003 (-0.21%)
After-hours: Mar 28, 2025, 7:15 PM EDT
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $71.24 million as of March 28, 2025. Its market cap has decreased by -70.42% in one year.
Market Cap
71.24M
Enterprise Value
120.34M
1-Year Change
-70.42%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $71.24M, a decrease of -90.02%. That is a compound annual growth rate of -44.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 71.24M | -37.24% |
| Dec 31, 2024 | 113.50M | -52.61% |
| Dec 29, 2023 | 239.49M | -34.07% |
| Dec 30, 2022 | 363.24M | -36.24% |
| Dec 31, 2021 | 569.65M | -20.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.25B |
| UnitedHealth Group | 474.64B |
| Johnson & Johnson | 394.84B |
| AbbVie | 357.09B |
| Novo Nordisk | 308.71B |
| Abbott Laboratories | 227.92B |
| Merck & Co. | 225.26B |
| AstraZeneca | 225.00B |